Genix Pharmaceuticals Corporation (TSXV:GENX)
Canada · Delayed Price · Currency is CAD 0.0200
0.00 (0.00%)
At close: Aug 27, 2026
Genix Pharmaceuticals Cash Flow Statement
Financials in millions CAD. Fiscal year is November - October.
Millions CAD. Fiscal year is Nov - Oct.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 30, 2026 | Oct '25 Oct 31, 2025 | Oct '24 Oct 31, 2024 | Oct '23 Oct 31, 2023 | Oct '22 Oct 31, 2022 | Oct '21 Oct 31, 2021 |
Net Income | -0.31 | -0.34 | -0.07 | -4.4 | -1.07 | -1.65 |
Depreciation & Amortization | - | - | - | 0.55 | 0.56 | 0.54 |
Other Amortization | 0 | 0 | 0 | 0 | 0 | 0 |
Asset Writedown & Restructuring Costs | 0.01 | 0.01 | - | 3.46 | - | - |
Stock-Based Compensation | - | - | 0.03 | 0.06 | 0.26 | 0.81 |
Other Operating Activities | 0.18 | 0.17 | -0.17 | 0.06 | 0.04 | 0 |
Change in Accounts Receivable | 0 | 0 | -0 | 0.02 | -0.01 | 0 |
Change in Inventory | - | - | -0 | 0.01 | -0.17 | -0 |
Change in Accounts Payable | 0.01 | 0.01 | 0.04 | 0.03 | 0.18 | -0.09 |
Change in Other Net Operating Assets | 0.01 | 0.02 | -0 | -0 | -0 | -0.03 |
Operating Cash Flow | -0.1 | -0.12 | -0.19 | -0.22 | -0.22 | -0.43 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 30, 2026 | Oct '25 Oct 31, 2025 | Oct '24 Oct 31, 2024 | Oct '23 Oct 31, 2023 | Oct '22 Oct 31, 2022 | Oct '21 Oct 31, 2021 |
Sale (Purchase) of Intangibles | - | - | - | - | -0 | - |
Investing Cash Flow | - | - | - | - | -0 | - |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 30, 2026 | Oct '25 Oct 31, 2025 | Oct '24 Oct 31, 2024 | Oct '23 Oct 31, 2023 | Oct '22 Oct 31, 2022 | Oct '21 Oct 31, 2021 |
Short-Term Debt Issued | - | 0.09 | 0.19 | 0.28 | 0.17 | - |
Total Debt Issued | 0.04 | 0.09 | 0.19 | 0.28 | 0.17 | - |
Long-Term Debt Repaid | - | -0.03 | - | - | -0.02 | -0.01 |
Lease Payments | - | - | - | - | -0.02 | -0.01 |
Total Debt Repaid | -0.03 | -0.03 | - | - | -0.02 | -0.01 |
Net Debt Issued (Repaid) | 0.01 | 0.06 | 0.19 | 0.28 | 0.15 | -0.01 |
Issuance of Common Stock | 0.1 | 0.1 | - | - | - | - |
Other Financing Activities | -0 | -0 | - | -0.06 | -0.05 | -0.12 |
Financing Cash Flow | 0.11 | 0.16 | 0.19 | 0.22 | 0.09 | -0.13 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 30, 2026 | Oct '25 Oct 31, 2025 | Oct '24 Oct 31, 2024 | Oct '23 Oct 31, 2023 | Oct '22 Oct 31, 2022 | Oct '21 Oct 31, 2021 |
Foreign Exchange Rate Adjustments | -0.01 | - | - | - | - | - |
Net Cash Flow | 0.01 | 0.03 | -0 | 0 | -0.13 | -0.56 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 30, 2026 | Oct '25 Oct 31, 2025 | Oct '24 Oct 31, 2024 | Oct '23 Oct 31, 2023 | Oct '22 Oct 31, 2022 | Oct '21 Oct 31, 2021 |
Free Cash Flow | -0.1 | -0.12 | -0.19 | -0.22 | -0.22 | -0.43 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | - | - | -4624.54% | -1787.27% | - | - |
Free Cash Flow Per Share | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.01 |
Levered Free Cash Flow | -0.16 | -0.15 | -0.53 | 0.06 | 0.17 | 0.68 |
Unlevered Free Cash Flow | -0.05 | -0.04 | -0.46 | 0.09 | 0.18 | 0.68 |
Free Cash Flow After Leases | -0.1 | -0.12 | -0.19 | -0.22 | -0.24 | -0.44 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 30, 2026 | Oct '25 Oct 31, 2025 | Oct '24 Oct 31, 2024 | Oct '23 Oct 31, 2023 | Oct '22 Oct 31, 2022 | Oct '21 Oct 31, 2021 |
Cash Interest Paid | - | - | - | - | 0 | - |
Change in Working Capital | 0.02 | 0.03 | 0.03 | 0.06 | -0.01 | -0.12 |